FSD Pharma Inc. (HUGE) Financials

HUGE Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 13.9 million 3.1 million
2023-06-30 16.2 million 4.4 million
2023-03-31 21.8 million 6.4 million
2022-12-31 28.3 million 5.8 million

HUGE Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -1.3 million 92831
2023-06-30 -2.7 million 304722
2023-03-31 -3.5 million 2.4 million
2022-12-31 -4.7 million 373583

HUGE Net Income

No data available :(

HUGE Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 3.2 million - 45846
2023-06-30 4.3 million - 88467
2023-03-31 6.8 million - 122568
2022-12-31 12.5 million - 159198

HUGE Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 28.8 million
2023-06-30 29.6 million
2023-03-31 28.8 million
2022-12-31 28.6 million

HUGE Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 24270 2.4 million -
2023-06-30 - 1.2 million 2.1 million -
2023-03-31 - 1.7 million 4.3 million -
2022-12-31 2155 2.0 million 2.1 million -

HUGE Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - -
2023-06-30 - -
2023-03-31 - -
2022-12-31 - -

HUGE

Price: $0.37

52 week price:
0.37
2.10

Earnings Per Share: -0.58 USD

P/E Ratio: -1.44

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 61417

Market Capitalization: 24.8 million

Links: